Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
Impact in
-
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Treatments and Studies
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 126
- Colorectal Cancer Screening and Detection 32
-
- Cancer Genomics and Diagnostics 18
- Top scholars
- Jean FaivreAnne‐Marie BouvierCôme LepageSylvain ManfrédiAlexis DesmoulièreOlivier CoatmeurRodrigue RossignolCyril Hatem
- Journals
- PLoS ONE (16 papers)Frontiers in Immunology (10 papers)European Journal of Cancer Prevention (10 papers)Journal of Investigative Dermatology (9 papers)Gut (8 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
584 papers receiving 20.3k citations
Peers
Comparison fields: 5 of 200
- Oncology 4.9k
- Cancer Research 2.3k
- Hepatology 1.0k
- Cell Biology 2.1k
- Pathology and Forensic Medicine 1.9k
Countries citing scholars working at Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
This map shows the geographic impact of research produced by authors working at Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers more than expected).
Fields of papers published by authors at Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
This network shows the impact of papers affiliated with Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers at the time of their publication.
About Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers
In recent decades, authors affiliated with Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers have published 675 papers, which have received a total of 23.6k indexed citations . Scholars at this organization have produced 126 papers in Oncology, 65 papers in Cancer Research, 75 papers in Pathology and Forensic Medicine, 39 papers in Genetics and 56 papers in Cell Biology on the topics of Colorectal Cancer Screening and Detection (32 papers), Genetic factors in colorectal cancer (31 papers), melanin and skin pigmentation (26 papers), Lymphoma Diagnosis and Treatment (22 papers), Gastric Cancer Management and Outcomes (20 papers), Cancer Genomics and Diagnostics (18 papers), DNA Repair Mechanisms (17 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Their work is cited by papers focused on Oncology (4.9k citations), Cancer Research (2.3k citations), Hepatology (1.0k citations), Cell Biology (2.1k citations) and Pathology and Forensic Medicine (1.9k citations). Authors at Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers collaborate with scholars in France, United States and Italy and have published in prestigious journals including PLoS ONE, Frontiers in Immunology, European Journal of Cancer Prevention, Journal of Investigative Dermatology and Gut. Some of Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers's most productive authors include Jean Faivre, Anne‐Marie Bouvier, Côme Lepage, Sylvain Manfrédi, Alexis Desmoulière, Olivier Coatmeur, Rodrigue Rossignol, Cyril Hatem, Caroline José and Giulio Gabbiani.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.